CD4 and infection: The proportion of men who experienced an immunological progression event (i.e., CD4+ T cell count < 350 cells/μL) within 2 years post-infection in the present study was 63%, which is higher than that reported in studies conducted in South West Africa (55%) and South Africa (44%) (17, 26).